← Back to Vaccine Database

SA 14-14-2

Live attenuated vaccine · VDDBV0672

Target & Classification

MeVMeasles virus
Live attenuated vaccine
Measles
ApprovedPhase 4 reached

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials3

Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT02880865 ApprovedMeasles
NCT00412516 Phase 3Measles
NCT00249769 Phase 3Measles